GAMCO Investors’s BioTelemetry, Inc. BEAT Stock Holding History

GAMCO Investors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-26,735	Closed	-$1.93M	–	958
2020 Q4	$1.93M	Buy	+26,735	New	+$1.4M	0.02%	496
2020 Q2	–	Sell	-19,952	Closed	-$768K	–	917
2020 Q1	$768K	Sell	19,952 -1,200	-6%	-$55.2K	0.01%	585
2019 Q4	$979K	Hold	21,152	–	–	0.01%	610
2019 Q3	$862K	Buy	21,152 +7,500	+55%	+$324K	0.01%	631
2019 Q2	$657K	Buy	13,652 +5,000	+58%	+$263K	0.01%	686
2019 Q1	$542K	Hold	8,652	–	–	﹤0.01%	669
2018 Q4	$517K	Sell	8,652 -11,900	-58%	-$714K	﹤0.01%	635
2018 Q3	$1.32M	Hold	20,552	–	–	0.01%	546
2018 Q2	$925K	Sell	20,552 -5,676	-22%	-$226K	0.01%	586
2018 Q1	$814K	Buy	26,228 +1,600	+6%	+$52.6K	0.01%	595
2017 Q4	$736K	Buy	+24,628	New	+$713K	﹤0.01%	624

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

GAMCO Investors's BEAT Position: Q1 2021 in Review

GAMCO Investors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 26,735 shares — an estimated $1.93M sold.

GAMCO Investors first reported a position in BEAT in Q4 2017 and held it in 11 quarters. The position peaked at $1.93M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

GAMCO Investors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
GAMCO Investors sold 26,735 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.93M.
GAMCO Investors first reported a position in BioTelemetry, Inc. in Q4 2017 and held it in 11 quarters.
GAMCO Investors's BioTelemetry, Inc. position peaked at $1.93M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on GAMCO Investors's 13F filing for Q1 2021, filed 14 May 2021.